Shanghai Aohua Photoelectricity Endoscope (688212.SH) issues a profit warning, expecting a net profit of 15.73 million to 23.38 million yuan for the year 2024, a year-on-year decrease of 59.59% to 72.81%.
Australia China Endoscope (688212.SH) issued a notice, the company expects to achieve attributable to owners of the parent company in 2024...
Shanghai Aohua Photoelectric Endoscope (688212.SH) announced that the company expects to achieve a net profit attributable to the owner of the parent company of 15.73 million to 23.38 million in 2024. Compared with the same period last year, it will decrease by 34.4744 million to 42.1244 million, a year-on-year decrease of 59.59% to 72.81%.
Related Articles

Jiangsu Boqian New Materials Stock (605376.SH) plans to start preparatory work for going public on the H-share market.

Industrial (601377.SH) has been approved to issue short-term corporate bonds not exceeding 10 billion yuan.

Beijing Sun-Novo Pharmaceutical Research (688621.SH): ABA001 injection received approval for clinical trials of pharmaceuticals
Jiangsu Boqian New Materials Stock (605376.SH) plans to start preparatory work for going public on the H-share market.

Industrial (601377.SH) has been approved to issue short-term corporate bonds not exceeding 10 billion yuan.

Beijing Sun-Novo Pharmaceutical Research (688621.SH): ABA001 injection received approval for clinical trials of pharmaceuticals






